BERGSTEIN IVAN (Chief Executive Officer) sold 2.1% of their position (57.22K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $635.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/15/2019ACC: 0001104659-19-015345
DirectorOfficer· Chief Executive Officer
Since Sep 2018
-57.22K
Net shares
Net seller
$635.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
57.22K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−55.07K
Price / share
$11.11
Trade value
$611.86K
% of position
2.0%
3/11/2019
2.72M→2.66M
Common Stock
Direct
Shares
−2.15K
Price / share
$11.05
Trade value
$23.77K
% of position
0.1%
3/12/2019
2.66M→2.66M
Total
Net shares
−57.22K
Net value
-$635.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2019 | S · Sale | −55.07K | $11.11 | $611.86K | 2.0% | 2.72M | 2.66M |
| Common Stock Direct | 3/12/2019 | S · Sale | −2.15K | $11.05 | $23.77K | 0.1% | 2.66M | 2.66M |
| Total | −57.22K | -$635.63K | ||||||
Derivative Transactions0
No derivative transactions reported